{
    "Trade/Device Name(s)": [
        "VITEK\u00ae 2 Compact",
        "VITEK 2 Compact System"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K050002",
    "Predicate Device Reference 510(k) Number(s)": [
        "N50510/S082"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "February 17, 2005",
    "Summary Letter Received Date": "January 3, 2005",
    "Submission Date": "December 30, 2004",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility Devices"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [],
    "Specimen Type(s)": [
        "Isolated colonies"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITEK\u00ae 2 Compact"
    ],
    "Method(s)/Technology(ies)": [
        "Automated antimicrobial susceptibility testing",
        "Optical growth monitoring",
        "Microdilution methodology"
    ],
    "Methodologies": [
        "Quantitative and qualitative susceptibility testing",
        "Minimum inhibitory concentration (MIC) determination"
    ],
    "Submission Type(s)": [
        "System",
        "Analyzer"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK\u00ae 2 Compact automated antimicrobial susceptibility testing system for isolated clinical colonies.",
    "Indications for Use Summary": "Intended to be used with VITEK\u00ae 2 AST Cards for automated susceptibility testing of isolated colonies from clinically significant aerobic gram-negative bacilli, Staphylococcus spp., Enterococcus spp., Streptococcus agalactiae, and S. pneumoniae as a laboratory aid in determining in vitro susceptibility to antimicrobial agents.",
    "fda_folder": "Microbiology"
}